Lignum Medical

Injectable nanocellulose hydrogel made from Finnish birch for treating stress urinary incontinence, delivered with its own application device in a standard cystoscopic procedure. A bio-based alternative to the synthetic bulking agents in use today. Patented in Europe, the US and Japan. Aalto University spin-out (2023) built on preclinical work since 2019.

The row

Sector

Medtech & Digital Health

Stage

Pre-revenue — No sales yet

Location

Espoo

Founded

2023

Research origin

Aalto

Business ID

3385536-3 · Finnish trade register

Links

Where this sits on the map

Lignum Medical is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗